AbbVie for years delayed competition for its blockbuster drug Humira, at the expense of patients and taxpayers. The monopoly is about to end.
How a Drug Company Made $114 Billion by Gaming the U.S. Patent System
The New York Times – Business:
This post first appeared in The New York Times – Business. Read the original article.
Written by
in